Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › mesenchymal stromal cells

mesenchymal stromal cells

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of mesenchymal stromal cells

4 trials tracked of mesenchymal stromal cells.

4Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 4
  1. Phase 2 Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19) Completed
  2. Phase 2 Allo-HCT MUD for Non-malignant Red Blood Cell (RBC) Disorders: Sickle Cell, Thal, and DBA: Reduced Intensity Conditioning, Co-tx MSCs Completed
  3. Phase 2 Double-blind, Randomized, Controlled Clinical Trial to Assess Efficacy of MSC in Patients With COVID-19 ARDS Completed
  4. Phase 2 Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease) Completed

Showing the 4 most-cited and recently-updated of 4 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Mesenchymal stromal cells and MSC-derived extracellular vesicles may reprogram neuroimmune responses in neurodegenerative diseases
Hematology Sys. Review
Mesenchymal stromal cells and MSC-derived extracellular vesicles may reprogram neuroimmune responses in neurodegenerative diseases Stem cells and vesicles show potential for neurodegenerative diseases
This critical review examines the mechanisms and translational barriers of mesenchymal stromal cells (MSCs) and MSC-derived extracellular ve…
New research explores how stem cell products might protect the brain and repair blood-brain barriers in diseases like Parkinson's and Alzhei…
Frontiers Sep 29, 2026
Umbilical cord-derived mesenchymal stromal cells balance immune homeostasis and offer potential for inflammatory disease treatment
Allergy & Immunology Sys. Review
Umbilical cord-derived mesenchymal stromal cells balance immune homeostasis and offer potential for inflammatory disease treatment Mesenchymal Stromal Cells Show Promise for Autoimmune and Immune Disorders
This systematic review examines the immunomodulatory properties and translational challenges of umbilical cord-derived mesenchymal stromal c…
Umbilical cord cells may help balance the immune system in conditions like lupus and rheumatoid arthritis, though long-term safety data is s…
Frontiers Sep 15, 2026